| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reproductive Endocrinology |
Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory of the Beth Israel Deaconess Medical Center, Department of Internal Medicine, Division of Endocrinology and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School (C.S.M., J.S.F.), Boston, Massachusetts 02215; and the Department of Medicine, Section of Diabetes and Metabolism, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Address all correspondence and requests for reprints to: Jeffrey S. Flier, M.D., Division of Endocrinology, RN 325, Beth Israel Deaconess Medical Center, 99 Brookline Avenue, Boston, Massachusetts 02215. E-mail: jflier{at}bih.harvard.edu
The polycystic ovary syndrome (PCOS) is characterized by menstrual disturbances, chronic anovulation and hyperandrogenism and is associated with insulin resistance and hyperinsulinemia. Leptin, the product of the ob gene, is an adipocyte-secreted molecule that signals the magnitude of energy stores to the brain and has been recently shown to have important effects on the reproductive axis of rodents. To assess the potential contribution of leptin to the pathogenesis of PCOS, we measured leptin levels in 24 obese women with PCOS and 12 weight- and age-matched controls and determined whether alterations in hyperinsulinemia produced by administration of the insulin-sensitizing agent troglitazone had an effect on serum leptin levels. Leptin concentrations at baseline were not different in women with PCOS (38.1 ± 2.15 ng/mL) and controls (33.12 ± 2.39 ng/mL). Moreover, leptin concentrations remained unchanged after treatment with troglitazone (38.1 ± 2.15 vs. 39.21 ± 2.65 ng/mL). Baseline leptin correlated strongly with body mass index in both controls (r = 0.59; P < 0.05) and women with PCOS (r = 0.70; P = 0.0004). Leptin levels were not associated with baseline insulin, testosterone, non-sex hormone-binding globulin (SHBG)-bound testosterone, dehydroepiandrosterone sulfate, estradiol, or SHBG. Finally, despite significantly reduced insulin, non-SHBG-bound testosterone, and estradiol levels after troglitazone treatment of women with PCOS, their leptin levels remained unchanged. We conclude that circulating leptin levels in patients with PCOS do not differ from those in age- and weight-matched controls. Furthermore, increased circulating insulin due to insulin resistance does not appear to alter circulating leptin levels in women with PCOS.
This article has been cited by other articles:
![]() |
L. Manneras, I. H. Jonsdottir, A. Holmang, M. Lonn, and E. Stener-Victorin Low-Frequency Electro-Acupuncture and Physical Exercise Improve Metabolic Disturbances and Modulate Gene Expression in Adipose Tissue in Rats with Dihydrotestosterone-Induced Polycystic Ovary Syndrome Endocrinology, July 1, 2008; 149(7): 3559 - 3568. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manneras, S. Cajander, A. Holmang, Z. Seleskovic, T. Lystig, M. Lonn, and E. Stener-Victorin A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome Endocrinology, August 1, 2007; 148(8): 3781 - 3791. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.K. Ludwig, J.M. Weiss, S. Tauchert, T. Dietze, S. Rudolf, K. Diedrich, A. Peters, and K.M. Oltmanns Influence of hypo- and hyperglycaemia on plasma leptin concentrations in healthy women and in women with polycystic ovary syndrome Hum. Reprod., June 1, 2007; 22(6): 1555 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glintborg, M. Andersen, C. Hagen, J. Frystyk, V. Hulstrom, A. Flyvbjerg, and A. P. Hermann Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur. J. Endocrinol., August 1, 2006; 155(2): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Pagan, S. S. Srouji, Y. Jimenez, A. Emerson, S. Gill, and J. E. Hall Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome: Investigation of Hypothalamic and Pituitary Contributions J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1309 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hahn, U. Haselhorst, B. Quadbeck, S. Tan, R. Kimmig, K. Mann, and O. E Janssen Decreased soluble leptin receptor levels in women with polycystic ovary syndrome Eur. J. Endocrinol., February 1, 2006; 154(2): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Carmina, F Orio, S Palomba, T Cascella, R A Longo, A M Colao, G Lombardi, and R A Lobo Evidence for altered adipocyte function in polycystic ovary syndrome Eur. J. Endocrinol., March 1, 2005; 152(3): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Swain, R. L. Dunn, D. McConnell, J. Gonzalez-Martinez, and G. D. Smith Direct Effects of Leptin on Mouse Reproductive Function: Regulation of Follicular, Oocyte, and Embryo Development Biol Reprod, November 1, 2004; 71(5): 1446 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-{gamma} Polymorphisms in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5887 - 5892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Kero, E. Savontaus, M. Mikola, U. Pesonen, M. Koulu, R. A. Keri, J. H. Nilson, M. Poutanen, and I. T. Huhtaniemi Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E812 - E818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Legro, R. Bentley-Lewis, D. Driscoll, S. C. Wang, and A. Dunaif Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2128 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Mayerson, R. S. Hundal, S. Dufour, V. Lebon, D. Befroy, G. W. Cline, S. Enocksson, S. E. Inzucchi, G. I. Shulman, and K. F. Petersen The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, S. M. Pincus, M. C. Garcia-Rudaz, M. G. Ropelato, M. E. Escobar, and M. Barontini Disruption of the Synchronous Secretion of Leptin, LH, and Ovarian Androgens in Nonobese Adolescents with the Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3772 - 3778. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Spritzer, M. Poy, D. Wiltgen, L.S. Mylius, and E. Capp Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements Hum. Reprod., July 1, 2001; 16(7): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Azziz, D. Ehrmann, R. S. Legro, R. W. Whitcomb, R. Hanley, A. G. Fereshetian, M. OKeefe, and M. N. Ghazzi Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1626 - 1632. [Abstract] [Full Text] |
||||
![]() |
L. B. Williams, R. L. Fawcett, A. S. Waechter, P. Zhang, B. E. Kogon, R. Jones, M. Inman, J. Huse, and R. V. Considine Leptin Production in Adipocytes from Morbidly Obese Subjects: Stimulation by Dexamethasone, Inhibition with Troglitazone, and Influence of Gender J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2678 - 2684. [Abstract] [Full Text] |
||||
![]() |
C. S. MANTZOROS Role of Leptin in Reproduction Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S.Mantzoros, D. W.Cramer, R. F.Liberman, and R. L.Barbieri Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome Hum. Reprod., March 1, 2000; 15(3): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sun and J. Yu The Effect of a Special Herbal Tea on Obesity and Anovulation in Androgen-Sterilized Rats Experimental Biology and Medicine, March 1, 2000; 223(3): 295 - 301. [Abstract] [Full Text] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosenbaum and R. L. Leibel Role of Gonadal Steroids in the Sexual Dimorphisms in Body Composition and Circulating Concentrations of Leptin J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1784 - 1789. [Full Text] |
||||
![]() |
T. Sir-Petermann, V. Piwonka, F. Perez, M. Maliqueo, S.E. Recabarren, and L. Wildt Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome? Hum. Reprod., June 1, 1999; 14(6): 1435 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Mantzoros The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence Ann Intern Med, April 20, 1999; 130(8): 671 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Huber-Buchholz, D. G. P. Carey, and R. J. Norman Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1470 - 1474. [Abstract] [Full Text] |
||||
![]() |
I.E. Messinis, S.D. Milingos, E. Alexandris, I. Kariotis, G. Kollios, and K. Seferiadis Leptin concentrations in normal women following bilateral ovariectomy Hum. Reprod., April 1, 1999; 14(4): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Agarwal, K. Vogel, S. R. Weitsman, and D. A. Magoffin Leptin Antagonizes the Insulin-Like Growth Factor-I Augmentation of Steroidogenesis in Granulosa and Theca Cells of the Human Ovary J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1072 - 1076. [Abstract] [Full Text] |
||||
![]() |
L. C. Morin-Papunen, R. M. Koivunen, C. Tomás, A. Ruokonen, and H. K. Martikainen Decreased Serum Leptin Concentrations during Metformin Therapy in Obese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2566 - 2568. [Abstract] [Full Text] |
||||
![]() |
J. Licinio, A. B. Negrao, C. Mantzoros, V. Kaklamani, M.-L. Wong, P. B. Bongiorno, A. Mulla, L. Cearnal, J. D. Veldhuis, J. S. Flier, et al. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women PNAS, March 3, 1998; 95(5): 2541 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dunaif Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis Endocr. Rev., December 1, 1997; 18(6): 774 - 800. [Abstract] [Full Text] |
||||
![]() |
C. Karlsson, K. Lindell, E. Svensson, C. Bergh, P. Lind, H. Billig, L. M. S. Carlsson, and B. Carlsson Expression of Functional Leptin Receptors in the Human Ovary J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4144 - 4148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arroyo, G. A. Laughlin, A. J. Morales, and S. S. C. Yen Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3728 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Mantzoros, S. Moschos, I. Avramopoulos, V. Kaklamani, A. Liolios, D. E. Doulgerakis, I. Griveas, N. Katsilambros, and J. S. Flier Leptin Concentrations in Relation to Body Mass Index and the Tumor Necrosis Factor-{alpha} System in Humans J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3408 - 3413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Caro Leptin Is Normal in PCOS, An Editorial about Three "Negative" Papers J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1685 - 1686. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |